by TractManager | Dec 8, 2016 | Emerging Technology Report
An orally inhaled dihydroergotamine product for acute treatment of migraine headache.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Dec 8, 2016 | Health Technology Assessment
Purpose of Technology: Percutaneous vertebroplasty (VP) for the treatment of osteoporotic fractures is the injection of bone cement into the affected vertebrae with the intent of restoring structural integrity and preventing further bone collapse. Clinical goals...
by TractManager | Dec 8, 2016 | Health Technology Assessment
Purpose of Technology: Brachytherapy involves temporary implantation of radioactive materials at the site of a tumor. For treatment of breast cancer, brachytherapy is generally performed after breast-conserving surgery such as lumpectomy, either in the form of...
by TractManager | Dec 1, 2016 | Clinical Utility Evaluation
This report examines the clinical utility of genetic testing of unaffected individuals at risk for hereditary breast and ovarian cancer syndrome due to family history. This report provides an assessment of the evidence for the use of genetic testing in this...
by TractManager | Dec 1, 2016 | Health Technology Assessment
Purpose of Technology: Repetitive high-frequency left transcranial magnetic stimulation (HFL-rTMS) is a noninvasive technique that may serve as an alternative intervention for treatment-resistant depression (TRD). Brief repetitive pulses of magnetic energy are applied...
Recent Comments